| Composition of thrombi in zebrafish : similarities and distinctions with mammals | Journal of thrombosis and haemostasis |  | | 2024 | 180 | 0 |
|
| Regulation of fibrinogen synthesis | Thrombosis research |  | | 2024 | 96 | 31 |
|
| Hemostasis and thrombosis in the zebrafish: a vertebrate model for human coagulopathies | | | | 2023 | 178 | 13 |
|
| The XRN1-regulated RNA helicase activity of YTHDC2 ensures mouse fertility independently of m6A recognition | Molecular cell | | | 2022 | 102 | 211 |
|
| Chemical modulators of fibrinogen production and their impact on venous thrombosis | Thrombosis and Haemostasis | | | 2021 | 274 | 294 |
|
| Fibrin(ogen) in human disease: both friend and foe | Haematologica | | | 2020 | 484 | 436 |
|
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | | | 2020 | 316 | 377 |
|
| A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis | Blood Advances | | | 2020 | 220 | 280 |
|
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | | | 2020 | 252 | 207 |
|
| Local chromatin interactions contribute to expression of the fibrinogen gene cluster | Journal of Thrombosis and Haemostasis | | | 2018 | 544 | 195 |
|
| Inactivation of AMMECR1 is associated with growth, bone, and heart alterations | Human Mutation | | | 2018 | 596 | 416 |
|
| KIAA1109 Variants Are Associated with a Severe Disorder of Brain Development and Arthrogryposis | American Journal of Human Genetics | | | 2018 | 601 | 370 |
|
| The effect of genetic variation on promoter usage and enhancer activity | Nature Communications | | | 2017 | 377 | 222 |
|
| tfec controls the hematopoietic stem cell vascular niche during zebrafish embryogenesis | Blood | | | 2016 | 601 | 9 |
|
| GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability | American journal of human genetics | | | 2016 | 698 | 640 |
|
| Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques | PloS one | | | 2016 | 614 | 335 |
|
| Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes | Genomics | | | 2015 | 648 | 4 |
|
| Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes | Data in brief | | | 2015 | 696 | 338 |
|
| C2orf62 and TTC17 are involved in actin organization and ciliogenesis in zebrafish and human | PloS one | | | 2014 | 734 | 389 |
|
| Targeted mutation of zebrafish fga models human congenital afibrinogenemia | Blood | | | 2014 | 714 | 5 |
|
| DNA Methylation Profiling of the Fibrinogen Gene Landscape in Human Cells and during Mouse and Zebrafish Development | PloS one | | | 2013 | 686 | 399 |
|
| Fibrinogen gene regulation | Thrombosis and haemostasis | | | 2012 | 792 | 3 |
|
| Developmental expression and organisation of fibrinogen genes in the zebrafish | Thrombosis and haemostasis | | | 2012 | 747 | 7 |
|
| A novel regulatory element between the human FGA and FGG genes | Thrombosis and haemostasis | | | 2012 | 717 | 0 |
|
| A liver enhancer in the fibrinogen gene cluster | Blood | | | 2011 | 674 | 3 |
|
| Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase | Thrombosis and haemostasis | | | 2011 | 630 | 435 |
|
| Regulation of fibrinogen production by microRNAs | Blood | | | 2010 | 636 | 0 |
|
| Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A' | Thrombosis and haemostasis | | | 2010 | 689 | 356 |
|
| Generation of human inflammation-resistant endothelial progenitor cells by A20 gene transfer | Journal of vascular research | | | 2010 | 659 | 0 |
|
| Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | | | 2008 | 680 | 8 |
|
| Retinoids and activation of PKC induce tissue-type plasminogen activator expression and storage in human astrocytes | Journal of thrombosis and haemostasis | | | 2008 | 705 | 0 |
|
| Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model | Cancer gene therapy | | | 2008 | 561 | 0 |
|
| Role of Gas6 in erythropoiesis and anemia in mice | The Journal of clinical investigation | | | 2008 | 749 | 174 |
|
| Characterization of endothelial-like cells derived from human mesenchymal stem cells | Journal of thrombosis and haemostasis | | | 2007 | 604 | 1 |
|
| Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques | Thrombosis and haemostasis | | | 2007 | 623 | 256 |
|
| Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues | Biochemical journal | | | 2007 | 647 | 376 |
|
| Gene conversion limits divergence of mammalian TLR1 and TLR6 | BMC evolutionary biology | | | 2007 | 616 | 371 |
|
| Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells | Stem cells |  | | 2006 | 624 | 0 |
|
| Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis | Experimental cell research | | | 2006 | 668 | 648 |
|
| Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies | Thrombosis and haemostasis | | | 2005 | 720 | 486 |
|
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | | | 2004 | 719 | 1 |
|
| Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors | BMC molecular biology | | | 2004 | 620 | 271 |
|
| Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES | Antimicrobial agents and chemotherapy | | | 2003 | 668 | 108 |
|
